QUOTE AND NEWS
TheStreet.com  Apr 26  Comment 
span.style4 {font-size: 10px; font-weight: bold; } span.style5 {font-size: 10px} By Jonathan Moreland, founder of Insider Insights and author of Profit From Legal Insider Trading. NEW YORK (TheStreet) -- It is a victory for common...
TheStreet.com  Apr 11  Comment 
span.style4 {font-size: 10px; font-weight: bold; } span.style5 {font-size: 10px} By Jonathan Moreland, founder of Insider Insights and author of Profit From Legal Insider Trading. NEW YORK (TheStreet) -- It is a victory for common...
TheStreet.com  Apr 6  Comment 
Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener. NEW YORK (TheStreet) -- Here are some of the hot stocks Jim Cramer talked about on Friday's "Mad Money" on CNBC: ARCP data by...
TheStreet.com  Mar 21  Comment 
span.style4 {font-size: 10px; font-weight: bold; } span.style5 {font-size: 10px} By Jonathan Moreland, founder of Insider Insights and author of Profit From Legal Insider Trading. NEW YORK (TheStreet) -- It is a victory for common...
Benzinga  Mar 20  Comment 
In a report published Wednesday, Jefferies analyst Eun K. Yang reiterated a Buy rating on Opko Health (NYSE: OPK), and slightly raised the price target from $8.00 to $9.00. In the report, Yang noted, “Estimated current cash of ~$187M...
StreetInsider.com  Mar 4  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Opko+Health+%28OPK%29+Completes+Transaction+with+Cytochroma/8153236.html for the full story.
TheStreet.com  Feb 28  Comment 
span.style4 {font-size: 10px; font-weight: bold; } span.style5 {font-size: 10px} By Jonathan Moreland, founder of Insider Insights and author of Profit From Legal Insider Trading. NEW YORK (TheStreet) -- It is a victory for...
StreetInsider.com  Feb 8  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/OPKO+Health+%28OPK%29+Rebounds+after+Addressing+Insider+Selling+Concerns/8074926.html for the full story.
Benzinga  Feb 8  Comment 
OPKO Health, Inc. (NYSE: OPK), in response to statements regarding the sale of Company common stock by Mr. Adam E. Logal, OPKO's Vice President, Chief Accounting Officer and Treasurer, would like to clarify that no other Company officer has...
StreetInsider.com  Jan 25  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/OPKO+Health+%28OPK%29+Prices+%24175M+Convertible+Notes+Offering/8031786.html for the full story.





You may also be interested in articles related to Opko Health Inc (OPK):
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki